EUR/USD 1.19200
0.832%
Gold 5036.55
1.682%
Oil 63.856
0.877%
USD/JPY 155.667
-0.909%
GBP/USD 1.36552
0.272%
GBP/JPY 212.569
-0.640%
Browse More
  • English
  • 简体中文
  • 繁體中文
  • Tiếng Việt
  • ไทย
  • Indonesia
Subscribe
Real-time News
On February 9th, Guansheng Co., Ltd. issued an announcement stating that it has noticed reports published by some media outlets online regarding "Guansheng Co., Ltd.s release of an intelligent bionic articulated arm in Shanghai." The reports claimed that the companys core component business for humanoid robots has entered the commercial mass production stage, and that its intelligent bionic articulated arm product has received over a thousand intended orders in the field of biomedical experimental equipment. The company clarified that the aforementioned reports are a misinterpretation by the media and do not represent the companys statements. The company will contact the relevant media outlets as soon as possible to delete the inaccurate statements and pursue relevant responsibilities to protect the companys reputation and legitimate rights, and safeguard the interests of its investors. The companys main business has not changed and remains focused on the research, development, production, and sales of automotive chassis system components. Currently, the intelligent bionic articulated arm product has no orders and has not generated any revenue. The wording in the related media reports is inaccurate; the product has not yet entered the mass production stage and is still a long way from mass production.On February 9th, Zhongmiao Holdings (01471.HK) announced in Hong Kong that its board of directors has noted the recent increase in the companys share price and trading volume. The board is pleased to announce that it has submitted an application to the China Securities Regulatory Commission (CSRC) to convert 105,895,600 unlisted domestic shares into H shares. Subject to obtaining all filings and/or approvals from relevant regulatory authorities (including but not limited to the CSRC and the Stock Exchange of Hong Kong), and upon compliance with all applicable laws and regulations, these unlisted shares will be converted into H shares and eligible for listing and trading on the Stock Exchange of Hong Kong.According to Hong Kong Stock Exchange documents, Vidali Technology Co., Ltd. has submitted a listing application to the Hong Kong Stock Exchange.According to Hong Kong Stock Exchange documents, Hangzhou Relian Group Co., Ltd. has submitted a listing application to the Hong Kong Stock Exchange.Oracle (ORCL.N) shares surged 6% intraday, marking the biggest gain since December of last year.

Silver price analysis: XAG/USD declines from a 13-day-old resistance line below $21.00

Daniel Rogers

Mar 13, 2023 11:37

 截屏2022-07-29 上午11.05.40.png

 

Silver price (XAG/USD) maintains modest gains near $20.60 as it probes the metal's retreat from a key short-term resistance line on Monday morning. Despite this, the XAG/USD maintains its three-day winning trend and extends yesterday's recovery from the lowest levels since November 4, 2022.

 

Nonetheless, the impending bear cross on the MACD and the bullion's inability to remain above the 200-SMA, not to mention the failure to cross a two-week-old resistance line, give Silver price bears reason for optimism.

 

Consequently, the bullion remains on track to retest the two-week-old horizontal support zone close to $20.40. However, the metal's further decline may make it difficult to break the $20.00 psychological magnet.

 

The focus will then shift to the monthly low of $19.95 and the November 2022 low around $18.85.

 

On the contrary, recovery movements remain elusive unless the XAG/USD remains below the downward-sloping resistance line from late February, around $20.90 at the latest. The $21.00 round number also functions as an upside filter.

 

The previous week's high near $21.30 may serve as the last line of defense for the XAG/USD skeptics if Silver purchasers maintain control above $21.00.


Suggestion